Diagnostic of visceral leishmaniasis by polymerase chain reaction PCR in experimental mice infected which treatment with Viscum album extract and Pentostam.

Main Article Content

Maksood A.M. Al-Doori
Tawfiq I . Al-Alousi
Abdulla H. Al-Jboori

Abstract

Visceral leishmaniasis (VL), or kala-azar, is an infection of the reticuloendothelial system, Fatalities due to leishmaniasis are associated with visceral disease. the  Leishmaia donovani   is a causative agent for this disease. In the current study, white male mice of the Balb /C strain were experimentally infected with the leishmania donovani promastigotes  and were then treated with a Viscum extract and compared with the Pentostam. The aim of this study was to evaluate the sensitivity and specificity of polymerase chain reaction (PCR) in the detection of Leishmania DNA in blood samples of infected mice. as well as, evaluation the ability of Viscum album extract to treatment the visceral leishmaniasis. The genetic study gave excellent results in the diagnosis of infection throughout the treatment period compared to the positive and negative control . Using  the specific LdI primer , the 700bp of the parasite was diagnosed. This Broad band was shown in the positive control samples, in the pantostam treatment groups, and the muscular injection with viscum extract in the first 15 days and in the   oral dosage  group in the first 20 days of initiation. While the band  did not appear in any other. The current study has shown promising results in the use of V. album in the treatment of visceral leishmaniasis and also gave impressive results in the diagnosis of infection PCR.

Article Details

How to Cite
Maksood A.M. Al-Doori, Tawfiq I . Al-Alousi, & Abdulla H. Al-Jboori. (2023). Diagnostic of visceral leishmaniasis by polymerase chain reaction PCR in experimental mice infected which treatment with Viscum album extract and Pentostam. Tikrit Journal of Pure Science, 22(11), 1–5. https://doi.org/10.25130/tjps.v22i11.904
Section
Articles

References

1- Alvar, J.; Velez, I.D; Bern, C.; Herrero, M.;

Desjeux, P.; Jannin, J.; den Boer, M. and WHO

Leishmaniasis Control Team.(2012). Leishmaniasis

worldwide and global estimates of its incidence.

PLoS One 7: e35671.

2- Wijeyaratne, P. M., L. K. Jones Arseault, and C.

J.Murphy.(1994). Endemicdiseases and development:

The leishmaniases. Acta Trop. 56:349–364.

3- Sacks, D. L. (2001). Leishmania-sand fly

interactions controlling species-specific vector

competence. Cell. Microbiol. 3:189–196.

4- Ostermann, T.; Raak, C. and Büssing, A.(2009)

Survival of cancer patients treated with mistletoe

extract (Iscador): a systematic literature review. BMC

Cancer, 451, 125-34.

5- Taiga, A.( 2013).Quantitative phytochemical

properties of mistletoe (V. album) from five different

plants. J, Agricultural and Environmental

Management Vol. 2(6), pp. 150-153 .

6- Li, Y.; Liang, F.; Jiang, W.; Yu, F.; Cao, R.; Ma,

Q.; Dai, X.; Jiang, J.; Wang, Y.; Si, S.(2007). DH334,

a beta-carboline Anti-Cancer Drug, Inhibits the CDK

Activity of Budding Yeast. Cancer Biol Ther. 6(8),

17-19.

7- Sakkas, H. ; Gartzonika, C. and Levidiotou, S.

(2016) Laboratory diagnosis of human visceral

leishmaniasis , J Vector Borne Dis 53, pp. 8–16.

8- Misra, P.; Khaliq, T.; Dixit, A.; Sen Gupta, S.;

Samant, M.; Kumar, A.; Kshawaha, PK.; Majumdar,

HH.; Saxena, AK.; Narender, t.; Dube, A. (2008).

Antileishmanial activity mediated by apoptosis and

structure-based target study of peganine

hydrochloride dehydrate: An approach for rational

drug design. J. antimichrobial Chemotherapy. 62(5),

998-1002.

9- Elmahallawy, E.K.; Sampedro M. A.; Rodriguez-

Granger, J.; Hoyos-Mallecot, Y.; Agil, A.; Navarro,

J.M. and Gutierrez F, J. (2014) Diagnosis of

leishmaniasis. J Infect Dev Ctries 8: 961-972.

doi:10.3855/jidc.4310.

10- de Queiroz, N. M.; da Silveira, R. C.; de Noronha,

A. C.; Oliveira, T. M.; Machado, R. Z. and Starke-

Buzetti, W. A. (2011). Detection of Leishmania (L.)

chagasi in canine skin. Vet Parasitol.

11- Salotra ,P.; Sreenivas, G.; Pogue ,G.P.; Lee, N.;

Nakhasi, H.L.; Ramesh, V. and Negi, N.S. (2001).

Development of a species-specific PCR assay for

detection of L. donovaniin clinical samples from

patients with kala-azar and post-kala-azar dermal

leishmaniasis. J ClinMicrobiol 39: 849-854.

12- Moore, G.E. and Woods, L.K. (1976). Culture

Media for Human Cells- RPMI 1603, RPMI 1634,

RPMI 1640 and GEM 1717. Tissue Culture

Association Manual. 3, 503-508.

13- Sundar, S.; Pai, K.; Kumar, R.; Tripathi, K. P.;

Gam, A. A.; Roy, M. and Kenny, R.T.(2001).

Resistance to treatment in kala-azar: speciation of

isolates from Northeast India. Am. J. Trop. Med.

Hyg. 65:193–196.

14- Al-Fahdi, B. K..; Hussein, F.H. and Hussein, I. A.

(2007). Effect of Equisetum arvense and

Urticapiluifera on the growth of promastigotes of

the leishmaniasis parasites, Tropical L. outside the

vivo. J. of Science, Vol. 18, No. 12, pp. 119-132.

15- Taskin, M.K.; Caliskan, O.A.; Abou – Gazar,

H.A.A.; Khan, I.A. and Bedir, E. (2005). Triterpene

Saponins from Nigella sativa L., Turk J. Chem,

29,561 – 569.

16- Bartlett, J. M.S. and Stirling, D.(2003). PCR

protocols: method in molecular biology. 2nd edi. Vol

226. Human Press.

17- Laurence, L.; Marchergui, H.S.; Chabbert, E.1.;

Jacques, D.; Dedet, J.P. and Bastien, P. (2002).

Comparison of Six PCR Methods Using Peripheral

Blood for Detection of Canine Visceral

Leishmaniasis. J. Clin. Microbiol., 40: 210-215.

18- Kamil, M. K. and Ali, H.Z.( 2016). Using PCR

for detection of cutaneous leishmaniasis in Baghdad.

Iraqi Journal of Science, Vol. 57, No.2B, pp:1125-

1130.

19- Osman, O. F.; Oskam, L.; Kroon, N. C. M.;

Schoone, G. J.; Khalil, E.T. A. G.; El Hassan, A.

M.; Zijlstra, E. E. and Kager, P. A.(1998 ).Use of

PCR for diagnosis of post-kala-azar dermal

leishmaniasis. J Clin Microbiol, 36, pp: 1621– 1624.

20- Ranasinghe, S.; Wickremasinghe, R.;

Hulangamuwa, S.; Sirimanna, G.; Opathella, N.;

Maingon, R.D.C. and Chandrasekharan, V.(2015).

Polymerase chain reaction detection of Leishmania

DNA in skin biopsy samples in Sri Lanka where the

causative agent of cutaneous leishmaniasis is L.

donovani, MemInst Oswaldo Cruz, Rio de Janeiro,

Vol. 110(8): 1017-1023 .

21- Yaseen, F. T. and Ali, H. Z. (2016).Using of

Species-Specific Primers for Molecular Diagnosis of

in vitroPromastigotes of L. donovani, Iraqi Journal of

Science, Vol. 57, No.2A, pp: 824-829.

22- Osman, O.F.; Oskam, L.; Zijlstra, E. E.; Kroon,

N. C.; Schoone, G. J.; Khalil, E. A. G.; Hassan, A.

M. and Karger, P. A. (1997). Evaluation of PCR for

diagnosis of visceral leishmaniasis. J Clin Microbiol,

35, pp: 2454–2457.